Viewing Study NCT01813305


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-01-11 @ 8:43 PM
Study NCT ID: NCT01813305
Status: COMPLETED
Last Update Posted: 2022-04-12
First Post: 2013-03-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: CSTC1 for Diabetic Foot Ulcers Phase II Study
Sponsor: Charsire Biotechnology Corp.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CSTC1-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View